Junichi Kodama

Junichi Kodama

UNVERIFIED PROFILE

Are you Junichi Kodama?   Register this Author

Register author
Junichi Kodama

Junichi Kodama

Publications by authors named "Junichi Kodama"

Are you Junichi Kodama?   Register this Author

50Publications

133Reads

25Profile Views

Three cases of struma ovarii underwent laparoscopic surgery with definite preoperative diagnosis.

Acta Med Okayama 2013 ;67(3):191-5

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://ousar.lib.okayama-u.ac.jp/50413
Publisher Site
http://dx.doi.org/10.18926/AMO/50413DOI Listing
October 2013

Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis.

Mol Clin Oncol 2013 Jul 14;1(4):737-744. Epub 2013 May 14.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Kita-ku, Okayama 700-8558, JapanDentistry and Pharmaceutical Sciences, Kita-ku, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
https://www.spandidos-publications.com/10.3892/mco.2013.120
Publisher Site
http://dx.doi.org/10.3892/mco.2013.120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915345PMC
July 2013

The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence.

Gynecol Oncol 2012 Dec 11;127(3):478-83. Epub 2012 Aug 11.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.07.123DOI Listing
December 2012

Changes in soluble fibrin levels during the perioperative period of gynecologic cancer surgery.

Oncol Lett 2012 Nov 31;4(5):1122-1124. Epub 2012 Aug 31.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2012.891DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499562PMC
November 2012

The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer.

Acta Med Okayama 2012 ;66(1):53-60

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.

View Article

Download full-text PDF

Source
http://ousar.lib.okayama-u.ac.jp/48081
Publisher Site
http://dx.doi.org/10.18926/AMO/48081DOI Listing
June 2012

[Mechanism of metastasis in cervical cancer].

Nihon Rinsho 2012 Jun;70 Suppl 4:100-3

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.

View Article

Download full-text PDF

Source
June 2012

Role of emmprin in endometrial cancer.

BMC Cancer 2012 May 28;12:191. Epub 2012 May 28.

Department of Obstetrics and Gynecology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1186/1471-2407-12-19
Web Search
http://www.biomedcentral.com/1471-2407/12/191
Publisher Site
http://dx.doi.org/10.1186/1471-2407-12-191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538063PMC
May 2012

Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.

Gynecol Oncol 2012 Feb 18;124(2):335-9. Epub 2011 Oct 18.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.10.014DOI Listing
February 2012

Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Eur J Nucl Med Mol Imaging 2012 Feb 10;39(2):283-90. Epub 2011 Nov 10.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kika-ku, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-011-1978-7DOI Listing
February 2012

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

Gynecol Oncol 2011 Oct 20;123(1):82-7. Epub 2011 Jul 20.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258110049
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2011.06.026DOI Listing
October 2011

Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.

Gynecol Oncol 2011 Sep 24;122(3):491-4. Epub 2011 Jun 24.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho Kita-ku, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258110043
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2011.05.038DOI Listing
September 2011

Fat accumulation in adipose tissues as a risk factor for the development of endometrial cancer.

Oncol Rep 2011 Jul 13;26(1):65-71. Epub 2011 Apr 13.

Department of Obstetrics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2011.1259DOI Listing
July 2011

The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer.

Int J Cancer 2011 Jun 4;128(11):2613-24. Epub 2010 Oct 4.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.25606
Publisher Site
http://dx.doi.org/10.1002/ijc.25606DOI Listing
June 2011

A pilot study of combination chemotherapy with paclitaxel, pirarubicin, and carboplatin (TPC) for endometrial carcinoma.

Int J Clin Oncol 2010 Oct 8;15(5):476-83. Epub 2010 Jun 8.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata, Kita-ku, Okayama, 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-010-0099-9DOI Listing
October 2010

Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma.

Int J Oncol 2010 Sep;37(3):605-14

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000709DOI Listing
September 2010

Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis.

Oncol Lett 2010 May 1;1(3):511-513. Epub 2010 May 1.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol_00000090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436453PMC
May 2010

Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.

J Surg Oncol 2010 Apr;101(5):413-7

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21499DOI Listing
April 2010

Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.

Oncol Rep 2010 Apr;23(4):917-25

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or_00000715DOI Listing
April 2010

α-fetoprotein-producing endometrial adenocarcinoma without an obvious hepatoid component.

Oncol Lett 2010 Mar 1;1(2):243-245. Epub 2010 Mar 1.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
https://www.spandidos-publications.com/10.3892/ol_00000043
Publisher Site
http://dx.doi.org/10.3892/ol_00000043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436455PMC
March 2010

The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.

Int J Gynecol Cancer 2010 Jan;20(1):110-5

Department of Gynecologic Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e3181c3a288DOI Listing
January 2010

The role of hepatocyte growth factor activator inhibitor-1 (HAI-1) as a prognostic indicator in cervical cancer.

Int J Oncol 2009 Aug;35(2):239-48

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
August 2009

Expression of matriptase and clinical outcome of human endometrial cancer.

Anticancer Res 2009 May;29(5):1685-90

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
May 2009

Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer.

Int J Oncol 2009 Feb;34(2):345-53

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
February 2009

Hepsin inhibits the cell growth of endometrial cancer.

Int J Mol Med 2008 Sep;22(3):389-97

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
September 2008

Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens.

Acta Med Okayama 2008 Aug;62(4):251-9

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558,Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/30944DOI Listing
August 2008

Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.

Oncol Rep 2008 May;19(5):1085-91

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
May 2008

Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.

Anticancer Res 2008 Jan-Feb;28(1A):159-64

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/28/1A/159.full.pdf
Web Search
April 2008

Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.

Gynecol Oncol 2007 Jun 12;105(3):757-61. Epub 2007 Apr 12.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.02.019DOI Listing
June 2007

Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus.

Eur J Obstet Gynecol Reprod Biol 2007 Mar 3;131(1):76-80. Epub 2006 Feb 3.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2006.01.006DOI Listing
March 2007

Chemotherapy for high-risk early-stage endometrial cancer.

Curr Opin Obstet Gynecol 2007 Feb;19(1):42-7

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GCO.0b013e32801127b7DOI Listing
February 2007

Risk factors for early and late postoperative complications of patients with endometrial cancer.

Eur J Obstet Gynecol Reprod Biol 2006 Feb 26;124(2):222-6. Epub 2005 Jul 26.

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2005.06.027DOI Listing
February 2006

Hepsin shows inhibitory effects through apoptotic pathway on ovarian cancer cell lines.

Int J Oncol 2006 Feb;28(2):393-8

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
February 2006

Parathyroid hormone-related protein as a potential tumor marker: a case report of ovarian clear cell carcinoma.

J Obstet Gynaecol Res 2006 Feb;32(1):94-8

Department of Obstetrics and Gynecology, Okayama University Medical School, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1447-0756.2006.00358.xDOI Listing
February 2006

Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.

Oncol Rep 2005 Jul;14(1):89-92

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
July 2005

Prognostic significance of the thymidine phosphorylate/dihydropyrimidine dehydrogenase ratio in invasive cervical cancer.

Eur J Obstet Gynecol Reprod Biol 2005 Jul;121(1):81-85

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
July 2005

Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer.

Gynecol Oncol 2005 Mar;96(3):776-83

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.

View Article

Download full-text PDF

Source
March 2005

SSX expression in gynecological cancers and antibody response in patients.

Cancer Immun 2004 Dec 17;4:16. Epub 2004 Dec 17.

Department of Immunology, Okayama University Graduate School of Medicine and Dentistry, Japan.

View Article

Download full-text PDF

Source
December 2004

[Mechanism of metastasis in cervical cancer].

Nihon Rinsho 2004 Oct;62 Suppl 10:78-81

Department of Obstetrics & Gynecology, Okayama University Graduate School of Medicine and Dentistry.

View Article

Download full-text PDF

Source
October 2004

Eradication of HPV post-surgical treatments, its correlation with specific types, types of surgery and the physical status.

Oncol Rep 2004 Aug;12(2):375-9

Department of Obstetrics and Gynecology, Okayama University Medical School, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
August 2004

A-kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis.

Int J Cancer 2004 Jan;108(1):86-90

Department of Immunology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.11565DOI Listing
January 2004

Heparanase messenger RNA expression in epithelial ovarian tumor.

Int J Mol Med 2003 Dec;12(6):961-4

Department of Obstetrics and Gynecology, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
December 2003

Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.

Cancer Res 2003 Nov;63(22):7834-9

Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
November 2003

[Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients].

Gan To Kagaku Ryoho 2003 Feb;30(2):243-9

Dept. of Obstetrics and Gynecology, Okayama University Medical School.

View Article

Download full-text PDF

Source
February 2003

Optimal surgery and diagnostic approach of stage IA2 squamous cell carcinoma of the cervix.

Eur J Obstet Gynecol Reprod Biol 2002 Mar;101(2):192-5

Department of Obstetrics and Gynecology, Okayama University Medical School, 2-5-1 Shikata-cho, 700-8558, Okayama, Japan.

View Article

Download full-text PDF

Source
March 2002